David Matthew T 4
4 · CorMedix Inc. · Filed Sep 8, 2020
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
David Matthew T
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-09-03$4.07/sh+1,150$4,681→ 1,150 total
Holdings
- 125,000
Stock Option (Right to Buy Common Stock)
Exercise: $5.63Exp: 2030-05-11→ Common Stock (125,000 underlying) - 125,000
Stock Option (Right to Buy Common Stock)
Exercise: $4.08Exp: 2030-05-11→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date.